Functionalized Isoxazoles to Augment Your Building Block Collection

Our Unique Building Blocks to Perform Far and Wide
8 June 2021
Oleg Lukin
Senior Research Scientist

Isoxazole derivatives are now of great interest in many fields of research and technology [1-2]. From the organic synthesis standpoint, these compounds are versatile synthetic building blocks owing to their dormant functionalities, e.g., as enaminones, [3] 1,3-dicarbonyl compounds, and γ-amino alcohols [4]. The substituted isoxazole unit is present in several natural products, synthetic drugs, and other biologically active compounds [5]. For example, ibotenic acid 1 (Fig. 1) and the product of its decarboxylation have been isolated from several fungal species and are active central nervous system (CNS) agents [6]. Up to the present 13 isoxazole-containing drugs possessing a wide spectrum of biological activities have been successfully marketed [7]. Among them are antirheumatic drug Leflunomide 2 and antipsychotic agent Paliperidone 3 (both shown in Fig. 1), to name but a few. Furthermore, many isoxazole derivatives exhibit properties attractive for their technological applications, e.g., fluorescent sensors, [8] ligands for asymmetric synthesis, [9] and liquid crystals [10].

Natural compounds and synthetic drugs containing the isoxazole fragment.

Figure 1. Natural compounds and synthetic drugs containing the isoxazole fragment.

Representatives of the isoxazole-containing compounds available from Life Chemicals are listed below. The full list of the functionalized isoxazoles can be obtained upon request by emailing

isoxazoles examples


  1. Morita, T.; Yugandar, S.; Fuse, S.; Nakamura, H. Tetrahedron Lett. 2018, 59, 1159-1171.
  2. Giomi, D.; Cordero, F.M.; Machetti, F. in Comprehensive Heterocyclic Chemistry, 3rd edition, eds. A.R. Katritzky, C.A. Ramsden, E.F.V. Scriven, and R. J.K. Taylor Pergamon, Oxford, 2008. Vol. 4, p. 365.
  3. Calle, M.; Calvo, L.A.; Gonzáles-Ortega, A.; Gonzáles-Nogal, A.M. Tetrahedron 2006, 62, 611.
  4. Aschwanden, P.; Kværno, L.; Geisser, R.W.; Kleinbeck, F.; Carreira, E.M. Org. Lett. 2005, 7, 5741.
  5. (а) Chikkula, K. V.; Raja, S. Int. J. Pharm. Pharmaceut. Sci. 2017, 9, 13-24. (b) Zhu, J.; Mo, J.; Lin, H.; Chen, Y.; Sun, H. Bioorg. Med. Chem. 2018, 26, 3065-3075.
  6. Liu, J.-K. Chem. Rev. 2005, 105, 2723.
  7.; accessed in July 2019.
  8. Yang, R.-H.; Chan, W.-H.; Lee, A.W.M.; Xia, P.-F.; Zhang, H.-K.; Li, K. J. Am. Chem. Soc. 2003, 125, 2884.
  9. Arai, M.A.; Kuraishi, M.; Arai, T.; H. Sasai, H. J. Am. Chem. Soc. 2001, 123, 2907.
  10. Haino, T.; Tanaka, M.; Ideta, K.; Kubo, K.; Mori, A.; Fukazawa, Y. Tetrahedron Lett. 2004, 45, 2277.
8 June 2021, 13:58 Oleg Lukin Building Blocks

Comments ()

    This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used. By using our website, you accept our conditions of use of cookies to track data and create content (including advertising) based on your interest. Accept